165 related articles for article (PubMed ID: 12126617)
21. Co-crystallization of Leptospira interrogans peptide deformylase with a potent inhibitor and molecular-replacement schemes with eight subunits in an asymmetric unit.
Zhou Z; Gong W
Acta Crystallogr D Biol Crystallogr; 2004 Jan; 60(Pt 1):137-9. PubMed ID: 14684909
[TBL] [Abstract][Full Text] [Related]
22. Crystallization and preliminary X-ray crystallographic analysis of peptide deformylase (PDF) from Bacillus cereus in ligand-free and actinonin-bound forms.
Park JK; Moon JH; Kim JH; Kim EE
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Jan; 61(Pt 1):150-2. PubMed ID: 16508119
[TBL] [Abstract][Full Text] [Related]
23. Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs.
Gao J; Liang L; Zhu Y; Qiu S; Wang T; Zhang L
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428963
[TBL] [Abstract][Full Text] [Related]
24. Structural basis for the design of antibiotics targeting peptide deformylase.
Hao B; Gong W; Rajagopalan PT; Zhou Y; Pei D; Chan MK
Biochemistry; 1999 Apr; 38(15):4712-9. PubMed ID: 10200158
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of time-dependent inhibition of polypeptide deformylase by actinonin.
Van Aller GS; Nandigama R; Petit CM; DeWolf WE; Quinn CJ; Aubart KM; Zalacain M; Christensen SB; Copeland RA; Lai Z
Biochemistry; 2005 Jan; 44(1):253-60. PubMed ID: 15628866
[TBL] [Abstract][Full Text] [Related]
26. Structure of peptide deformylase and identification of the substrate binding site.
Becker A; Schlichting I; Kabsch W; Schultz S; Wagner AF
J Biol Chem; 1998 May; 273(19):11413-6. PubMed ID: 9565550
[TBL] [Abstract][Full Text] [Related]
27. 2D-QSAR in hydroxamic acid derivatives as peptide deformylase inhibitors and antibacterial agents.
Gupta MK; Mishra P; Prathipati P; Saxena AK
Bioorg Med Chem; 2002 Dec; 10(12):3713-6. PubMed ID: 12413827
[TBL] [Abstract][Full Text] [Related]
28. Understanding the highly efficient catalysis of prokaryotic peptide deformylases by shedding light on the determinants specifying the low activity of the human counterpart.
Fieulaine S; Desmadril M; Meinnel T; Giglione C
Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):242-52. PubMed ID: 24531459
[TBL] [Abstract][Full Text] [Related]
29. Crystals of peptide deformylase from Plasmodium falciparum reveal critical characteristics of the active site for drug design.
Kumar A; Nguyen KT; Srivathsan S; Ornstein B; Turley S; Hirsh I; Pei D; Hol WG
Structure; 2002 Mar; 10(3):357-67. PubMed ID: 12005434
[TBL] [Abstract][Full Text] [Related]
30. Solution structure of nickel-peptide deformylase.
Dardel F; Ragusa S; Lazennec C; Blanquet S; Meinnel T
J Mol Biol; 1998 Jul; 280(3):501-13. PubMed ID: 9665852
[TBL] [Abstract][Full Text] [Related]
31. Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.
Lee MD; She Y; Soskis MJ; Borella CP; Gardner JR; Hayes PA; Dy BM; Heaney ML; Philips MR; Bornmann WG; Sirotnak FM; Scheinberg DA
J Clin Invest; 2004 Oct; 114(8):1107-16. PubMed ID: 15489958
[TBL] [Abstract][Full Text] [Related]
32. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
Lee SK; Choi KH; Lee SJ; Suh SW; Kim BM; Lee BJ
Bioorg Med Chem Lett; 2010 Aug; 20(15):4317-9. PubMed ID: 20615695
[TBL] [Abstract][Full Text] [Related]
33. Structures of Staphylococcus aureus peptide deformylase in complex with two classes of new inhibitors.
Lee SJ; Lee SJ; Lee SK; Yoon HJ; Lee HH; Kim KK; Lee BJ; Lee BI; Suh SW
Acta Crystallogr D Biol Crystallogr; 2012 Jul; 68(Pt 7):784-93. PubMed ID: 22751663
[TBL] [Abstract][Full Text] [Related]
34. Kinetic analyses and inhibition studies reveal novel features in peptide deformylase 1 from Trypanosoma cruzi.
Rodrígues-Poveda CA; Pérez-Moreno G; Vidal AE; Urbina JA; González-Pacanowska D; Ruiz-Pérez LM
Mol Biochem Parasitol; 2012; 182(1-2):83-7. PubMed ID: 22209909
[TBL] [Abstract][Full Text] [Related]
35. Hydroxamic acids as potent inhibitors of Fe(II) and Mn(II) E. coli methionine aminopeptidase: biological activities and X-ray structures of oxazole hydroxamate-EcMetAP-Mn complexes.
Huguet F; Melet A; Alves de Sousa R; Lieutaud A; Chevalier J; Maigre L; Deschamps P; Tomas A; Leulliot N; Pages JM; Artaud I
ChemMedChem; 2012 Jun; 7(6):1020-30. PubMed ID: 22489069
[TBL] [Abstract][Full Text] [Related]
36. 2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitors.
Apfel C; Banner DW; Bur D; Dietz M; Hubschwerlen C; Locher H; Marlin F; Masciadri R; Pirson W; Stalder H
J Med Chem; 2001 Jun; 44(12):1847-52. PubMed ID: 11384231
[TBL] [Abstract][Full Text] [Related]
37. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase.
Grant SK; Green BG; Kozarich JW
Bioorg Chem; 2001 Aug; 29(4):211-22. PubMed ID: 16256693
[TBL] [Abstract][Full Text] [Related]
38. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
Calí P; Naerum L; Mukhija S; Hjelmencrantz A
Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
[TBL] [Abstract][Full Text] [Related]
39. Peptide aldehyde inhibitors of bacterial peptide deformylases.
Durand DJ; Gordon Green B; O'Connell JF; Grant SK
Arch Biochem Biophys; 1999 Jul; 367(2):297-302. PubMed ID: 10395747
[TBL] [Abstract][Full Text] [Related]
40. A new subclass of the zinc metalloproteases superfamily revealed by the solution structure of peptide deformylase.
Meinnel T; Blanquet S; Dardel F
J Mol Biol; 1996 Sep; 262(3):375-86. PubMed ID: 8845003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
